Abstract
Abstract
Background
Pancreatic cancer (PC) remains a significant healthcare challenge due to its aggressive nature and poor prognosis. The current gold standard that combines imaging modalities, endoscopy, and biopsies has limited diagnostic efficacy due to various shortcomings.
Methods
We propose a feasibility study for the use of a bioimpedance biomarker to detect PC. The biomarker was evaluated in a double blind study on ex vivo pancreata of mice: 15 LSL-KrasG12D; LSL-p53R172H; Pdx1-Cre, 2 LSL-KrasG12D, and 9 wild type controls (Study 1). To determine if the biomarker can distinguish between PC and acute pancreatitis (AP), we challenged it with 18 cerulein-induced AP and 6 saline-injected controls (Study 2).
Results
The results from Study 1 showed 100% specificity and 94% sensitivity against histopathology outcomes; for Study 2 all AP and saline-injected pancreases were diagnosed as non-cancerous. Regression analysis revealed a positive correlation between biomarker and pathologically analyzed cancer-induced fibrosis (r(24)= 0.73 (p<0.001)).
Conclusion
These findings demonstrate the potential of this bioimpedance biomarker as a diagnostic tool for PC.
Publisher
Springer Science and Business Media LLC
Reference57 articles.
1. Globocan PS. Pancreas Statistics Globocan 2020 | WHO. 2020. https://gco.iarc.fr/today/data/factsheets/cancers/13-Pancreas-fact-sheet.pdf. Accessed 24 Nov 2023.
2. CancerStatisticsCenter. Analysis Tool | American Cancer Society - Cancer Facts & Statistics. 5-year relative survival, 2011-2017. 2022. https://cancerstatisticscenter.cancer.org/#!/data-analysis/SurvivalByStage.
3. Kato S, Honda K. Use of biomarkers and imaging for early detection of pancreatic cancer. Cancers. 2020;12(7):1965.
4. Young MR, Abrams N, Ghosh S, Rinaudo JAS, Marquez G, Srivastava S. Prediagnostic image data, artificial intelligence, and pancreatic cancer: a tell-tale sign to early detection. Pancreas. 2020;49(7):882–6.
5. Koul A, Baxi AC, Shang R, Meng X, Li L, Keilin SA, et al. The efficacy of rapid on-site evaluation during endoscopic ultrasound-guided fine needle aspiration of pancreatic masses. Gastroenterol Rep. 2018;6(1):45–8.